IRIS Accounts Production v23.2.0.158 10038393 Board of Directors Board of Directors 1.4.22 31.3.23 31.3.23 false true false false false true false Ordinary 0.01 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure100383932022-03-31100383932023-03-31100383932022-04-012023-03-31100383932021-03-31100383932021-04-012022-03-31100383932022-03-3110038393ns16:EnglandWales2022-04-012023-03-3110038393ns15:PoundSterling2022-04-012023-03-3110038393ns11:Director12022-04-012023-03-3110038393ns11:Director22022-04-012023-03-3110038393ns11:PrivateLimitedCompanyLtd2022-04-012023-03-3110038393ns11:SmallEntities2022-04-012023-03-3110038393ns11:AuditExempt-NoAccountantsReport2022-04-012023-03-3110038393ns11:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3110038393ns11:SmallCompaniesRegimeForAccounts2022-04-012023-03-3110038393ns11:FullAccounts2022-04-012023-03-311003839312022-04-012023-03-3110038393ns11:OrdinaryShareClass12022-04-012023-03-3110038393ns11:RegisteredOffice2022-04-012023-03-3110038393ns6:CurrentFinancialInstruments2023-03-3110038393ns6:CurrentFinancialInstruments2022-03-3110038393ns6:ShareCapital2023-03-3110038393ns6:ShareCapital2022-03-3110038393ns6:RetainedEarningsAccumulatedLosses2023-03-3110038393ns6:RetainedEarningsAccumulatedLosses2022-03-3110038393ns6:IntangibleAssetsOtherThanGoodwill2022-04-012023-03-3110038393ns6:PlantMachinery2022-04-012023-03-3110038393ns6:NetGoodwill2022-03-3110038393ns6:NetGoodwill2023-03-3110038393ns6:NetGoodwill2022-03-3110038393ns6:PlantMachinery2022-03-3110038393ns6:PlantMachinery2023-03-3110038393ns6:PlantMachinery2022-03-3110038393ns6:WithinOneYearns6:CurrentFinancialInstruments2023-03-3110038393ns6:WithinOneYearns6:CurrentFinancialInstruments2022-03-3110038393ns11:OrdinaryShareClass12023-03-31
REGISTERED NUMBER: 10038393 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 MARCH 2023

FOR

BIOEXCEL PUBLISHING LIMITED

BIOEXCEL PUBLISHING LIMITED (REGISTERED NUMBER: 10038393)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


BIOEXCEL PUBLISHING LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 MARCH 2023







DIRECTORS: Dr S P Clissold
W Dolben





REGISTERED OFFICE: 6 Green Lane Business Park
238 Green Lane
New Eltham
London
SE9 3TL





REGISTERED NUMBER: 10038393 (England and Wales)





ACCOUNTANTS: Andrew Cross & Co.
Chartered Certified Accountants
6 Green Lane Business Park
238 Green Lane
New Eltham
London
SE9 3TL

BIOEXCEL PUBLISHING LIMITED (REGISTERED NUMBER: 10038393)

BALANCE SHEET
31 MARCH 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 10,900 10,900
Tangible assets 5 189 252
11,089 11,152

CURRENT ASSETS
Stocks 3,304 4,122
Debtors 6 6,368 14,581
Cash at bank 1,775 4,224
11,447 22,927
CREDITORS
Amounts falling due within one year 7 107,375 94,533
NET CURRENT LIABILITIES (95,928 ) (71,606 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(84,839

)

(60,454

)

CAPITAL AND RESERVES
Called up share capital 8 200 200
Retained earnings (85,039 ) (60,654 )
SHAREHOLDERS' FUNDS (84,839 ) (60,454 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

BIOEXCEL PUBLISHING LIMITED (REGISTERED NUMBER: 10038393)

BALANCE SHEET - continued
31 MARCH 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2023 and were signed on its behalf by:




Dr S P Clissold - Director



W Dolben - Director


BIOEXCEL PUBLISHING LIMITED (REGISTERED NUMBER: 10038393)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2023

1. STATUTORY INFORMATION

Bioexcel Publishing Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Stocks
Work in progress is valued at the lower of cost and net realisable value.

Cost is calculated using the first-in, first-out method and includes all purchase, transport, and handling costs in bringing stocks to their present location and condition.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 April 2022
and 31 March 2023 10,900
NET BOOK VALUE
At 31 March 2023 10,900
At 31 March 2022 10,900

BIOEXCEL PUBLISHING LIMITED (REGISTERED NUMBER: 10038393)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 MARCH 2023

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2022
and 31 March 2023 1,313
DEPRECIATION
At 1 April 2022 1,061
Charge for year 63
At 31 March 2023 1,124
NET BOOK VALUE
At 31 March 2023 189
At 31 March 2022 252

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 6,275 14,543
Other debtors 93 38
6,368 14,581

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 464 431
Other creditors 106,911 94,102
107,375 94,533

8. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2023 2022
value: £    £   
200,000,000 Ordinary £0.00001 200 200